Skip to content

What Are the Duties of a Nurse on Carboprost?

5 min read

Postpartum hemorrhage (PPH) affects approximately 1-5% of births and is a leading cause of maternal mortality worldwide. Nurses play a critical role in managing this obstetric emergency, and a key responsibility is understanding what are the duties of a nurse on carboprost, a medication used to control uterine bleeding.

Quick Summary

This article outlines the comprehensive nursing duties involved in the administration and monitoring of carboprost. It details preparation, patient assessment, continuous vital sign and uterine tone monitoring, managing adverse effects, and providing crucial patient education for safety.

Key Points

  • Pre-Administration Assessment: The nurse must verify the physician's order, review the patient's medical history for contraindications like asthma or cardiac disease, and visually inspect the medication.

  • Deep Intramuscular (IM) Administration: Carboprost is administered via deep IM injection, and the nurse must follow the specific dosage and repetition interval ordered by the physician.

  • Vigilant Vital Sign Monitoring: Continuous monitoring of the patient's temperature, blood pressure, and heart rate is critical to detect potential adverse effects like hypertension or transient fever.

  • Uterine Response and Bleeding Assessment: The nurse must assess the frequency and quality of uterine contractions and the amount of vaginal bleeding to gauge the medication's effectiveness.

  • Respiratory Status Observation: Due to the risk of bronchospasm, particularly in patients with a history of asthma, the nurse must monitor for any signs of respiratory distress.

  • Management of Side Effects: Nurses should be prepared to manage common side effects such as severe nausea, vomiting, and diarrhea, often with pre-medication and symptomatic care.

  • Comprehensive Patient Education: The nurse is responsible for educating the patient on the purpose of the medication, expected side effects, and vital warning signs to watch for post-discharge.

In This Article

Carboprost: The Nurse's Role in Preparation and Administration

Carboprost, often known by its brand name Hemabate, is a synthetic prostaglandin (PGF2α analog) that induces powerful and sustained uterine contractions. It is a second-line treatment used for refractory postpartum hemorrhage (PPH) caused by uterine atony when first-line therapies like oxytocin have been ineffective. The nursing responsibilities for carboprost begin well before the medication is administered.

Pre-Administration Nursing Responsibilities

Before a single dose of carboprost is given, a nurse must perform several critical steps to ensure patient safety and medication efficacy. These include:

  • Confirming the Order: The nurse must verify the physician's order for carboprost, including the dosage, route, and frequency, ensuring it aligns with hospital protocols and the patient's condition.
  • Assessing Patient History: A thorough review of the patient's medical history is essential. Carboprost is contraindicated in patients with a history of asthma, active cardiovascular, pulmonary, renal, or hepatic disease. A nurse must also note any history of hypertension, anemia, or seizures.
  • Patient Education: Even in an emergency, the nurse should briefly explain the medication's purpose, its intended effect (controlling bleeding), and potential common side effects like nausea, vomiting, and fever.
  • Medication Preparation: The nurse must visually inspect the carboprost vial for particulate matter or discoloration before drawing the medication. The initial dose of carboprost for postpartum hemorrhage is typically given via deep intramuscular (IM) injection.
  • Pre-medicating for Side Effects: To minimize the very common gastrointestinal side effects, the nurse may administer a prescribed antiemetic and antidiarrheal medication before or concurrently with carboprost, as per the physician's order.

Continuous Monitoring and Managing Adverse Effects

Once carboprost is administered, continuous and vigilant patient monitoring is paramount for safe and effective care. A nurse's duties extend to observation, intervention, and clear communication with the healthcare team.

Essential Patient Monitoring

The nurse's monitoring responsibilities include:

  • Uterine Response: Monitor the frequency, duration, and strength of uterine contractions and the resting tone. The nurse must notify the provider if contractions are absent or if excessive contractions occur, which could indicate uterine rupture.
  • Vital Signs: Continuous monitoring of the patient's temperature, blood pressure (BP), and heart rate (HR) is vital. A transient fever is a common side effect, but the nurse must differentiate it from an infection. Hypertension can also occur, and close monitoring helps identify potential cardiac compromise.
  • Vaginal Discharge: Assess the amount and type of vaginal discharge to monitor for effective hemorrhage control. Increased bleeding, especially if accompanied by hypotension and tachycardia, is a sign of continued hemorrhage and must be reported immediately.
  • Respiratory Status: Since carboprost can cause bronchospasm, especially in patients with asthma, the nurse must assess for signs of respiratory distress, including wheezing, shortness of breath, and chest tightness.
  • Anaphylaxis Watch: Monitor for signs of anaphylaxis, a serious but rare allergic reaction, which can present as wheezing, dyspnea, rash, or swelling of the face, lips, and throat.

Comparison of Uterotonics in Postpartum Hemorrhage Management

Nurses must be aware of the key differences between various uterotonic medications to understand why carboprost may be used in certain situations. The following table compares carboprost with other common uterotonics, methergine and oxytocin.

Feature Carboprost (Hemabate) Methylergonovine (Methergine) Oxytocin (Pitocin)
Mechanism of Action Synthetic prostaglandin (PGF2α analog) causing potent uterine contractions. Ergot alkaloid causing sustained uterine contractions. Synthetic hormone mimicking natural oxytocin to induce uterine contractions.
Route of Administration Deep intramuscular (IM) injection. Intramuscular (IM) or intravenous (IV) in emergency settings. Intravenous (IV) infusion; common first-line treatment.
Primary Indication Refractory PPH due to uterine atony. Refractory PPH; not for patients with hypertension. First-line treatment for PPH due to uterine atony.
Major Side Effects Diarrhea, nausea, vomiting, fever, chills, hypertension, bronchospasm. Hypertension, headache, seizure, abdominal pain, nausea, vomiting. Nausea, vomiting, hypotension, arrhythmias.
Key Contraindication Active cardiac, pulmonary, renal, or hepatic disease, asthma. Hypertensive disorders, preeclampsia, cardiac disease. Hypersensitivity, certain obstetric contraindications.

Responding to Complications and Providing Patient Education

The nurse's duties extend to managing complications and ensuring the patient is well-informed about their care and what to expect after discharge. Recognizing and responding to complications is vital for patient outcomes.

Nursing Interventions for Complications

  • Managing GI Distress: The nurse should provide supportive care for nausea, vomiting, and diarrhea, which are very common side effects. Pre-medication is often ordered, but symptomatic treatment with antiemetics may be needed. Stool precautions should also be considered to prevent contamination.
  • Addressing Drug-Induced Fever: If a fever develops, the nurse must assess for other signs of infection, such as foul-smelling vaginal discharge or lower abdominal pain. If infection is ruled out, the fever is likely drug-induced and will resolve once the therapy is complete.
  • Monitoring for Uterine Rupture: While rare, excessive uterine contractions can lead to uterine rupture, especially in patients with a history of a compromised uterus. Any signs of severe pain, loss of uterine tone, or bleeding should be reported immediately. The nurse is responsible for reporting these findings and preparing for potential surgical intervention.

Patient and Family Education

Patient education is a key nursing duty, even when care is complex and time-sensitive. The nurse should reinforce the following:

  • Expected Side Effects: Inform the patient about common side effects like chills, fever, and GI upset, and the purpose of any pre-medication.
  • Post-Discharge Warning Signs: Instruct the patient to contact their healthcare provider immediately if they experience persistent fever, foul-smelling vaginal discharge, severe lower abdominal pain, or increased bleeding. These can be signs of complications like endometritis or retained placental fragments.
  • Storage and Handling: For outpatient use, the nurse should explain how to store the medication properly, though carboprost is typically only administered in a hospital setting.

Conclusion

In summary, the nursing duties for a patient receiving carboprost are extensive, requiring a high level of vigilance and skill. From a careful pre-administration assessment, including a detailed medical history and confirmation of contraindications, to continuous post-administration monitoring of vital signs, uterine response, and adverse effects, the nurse's role is indispensable. Managing common side effects and providing essential patient education further ensures optimal outcomes. Carboprost is a powerful tool in controlling postpartum hemorrhage, and its safe and effective use is dependent on the critical thinking and clinical judgment of the nursing staff.

For more detailed information on specific drug indications and administration, consult a comprehensive drug guide like Davis's Drug Guide.

Frequently Asked Questions

Carboprost, or Hemabate, is a synthetic prostaglandin (PGF2α analog) used primarily to treat severe postpartum hemorrhage (PPH) caused by uterine atony when other treatments have failed. It works by causing the uterus to contract powerfully and stop bleeding.

Nurses should anticipate and manage common side effects including severe diarrhea, nausea, vomiting, a transient fever, and chills. Prophylactic antiemetics and antidiarrheals are often given to mitigate these issues.

If a fever develops, the nurse must assess for signs of infection, such as foul-smelling vaginal discharge. If infection is ruled out, it is likely a transient, drug-induced fever that should resolve after the therapy ends.

A major contraindication for carboprost is asthma or reactive airway disease. The medication can cause severe bronchospasm, and nurses must carefully review the patient's history for any respiratory issues before administration.

Carboprost is typically administered by a nurse via a deep intramuscular (IM) injection. The dose and frequency are determined by the physician.

After administration, a nurse must monitor the patient's vital signs (BP, HR, temp), the amount and type of vaginal bleeding, uterine contractions, and respiratory status for any signs of distress.

Nurses should inform patients about expected side effects like GI upset and fever. Importantly, they must educate patients on signs of potential complications, such as persistent fever, foul-smelling discharge, or increased bleeding, and when to seek immediate medical attention.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.